Bluejay Diagnostics (BJDX) Total Debt (2020 - 2021)
Bluejay Diagnostics (BJDX) posted Total Debt of $12000.0 for Q4 2021, down 90.41% sequentially from $125102.0 in Q3 2021, and down 90.41% YoY from $125102.0 in Q4 2020.
Bluejay Diagnostics (BJDX) Total Debt (2020 - 2021) Analysis & Trends
Bluejay Diagnostics has reported Total Debt for 2 years, with the latest figure at $12000.0 in Q4 2021.
- Quarterly Total Debt fell 90.41% year-over-year to $12000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $12000.0 (down 90.41% YoY) and the FY2021 annual result came in at $12000.0, down 90.41% from the prior year.
- Total Debt retreated to $12000.0 in Q4 2021 per BJDX's latest filing, from $125102.0 in the prior quarter.
- Over five years, Total Debt peaked at $125102.0 in Q4 2020 and troughed at $12000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 32.61 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 14.94 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 27.96 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 12.62 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 10.10 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 8.68 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 1.89 Bn |
| 10 | Bluejay Diagnostics | 1.89 Mn | 1.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | 125,102.00 |
| Dec 31, 2020 | 125,102.00 |